CHCHD2 and non-small cell lung carcinoma: Although reports showed that higher CCT6A and CHCHD2 expressions were correlated with the worse clinical outcomes of NSCLC [30], the prognosis of CCT6A and CHCHD2 in NSCLC LUSC subtype was not significant, suggesting the unique functions of CCT6A and CHCHD2 in contribution of the development and progression of LUAD.